DeflaGyn

DeflaGyn is a vaginal gel classified as a Class IIa medical device used for the treatment of cervical lesions, unclear cervical smears, and HPV-induced cervical abnormalities, including cervical intraepithelial neoplasia (CIN 1 and CIN 2). Developed by DEFLAMED International, the formulation contains highly dispersed silicon dioxide, citric acid, and sodium selenite. Its primary mechanism of action involves the adsorptive binding of pathogens, such as viruses and bacteria, and the provision of antioxidant effects through its patented DEFLAMIN combination (sodium selenite and citric acid). It is typically used during the 'watchful waiting' period to promote the regression of lesions and clear high-risk HPV infections, with clinical studies demonstrating significant efficacy in lesion regression compared to controls.

Brand names

DeflaGyn

Other names

DEFLAMIN